アニマルヘルス市場：製品タイプ別、動物タイプ別、エンドユーザー別-2025-2030年の世界予測

アニマルヘルス市場は2023年に838億5,000万米ドルと評価され、2024年には906億2,000万米ドルに達すると予測され、CAGR 8.38%で成長し、2030年には1,473億8,000万米ドルに達すると予測されています。

アニマルヘルス市場の範囲は、家畜や家禽からコンパニオンアニマルに至るまで、動物に影響を及ぼす疾病の予防、診断、治療に関わる産業や部門を網羅しています。この市場は、食の安全、公衆衛生、動物福祉の確保において重要な役割を果たしています。この市場の必要性は、人獣共通感染症の蔓延、タンパク質需要の増加に対応するための家畜生産の増加、ペット産業に拍車をかける人間と動物の絆の強化から生じています。用途としては、医薬品、ワクチン、診断ツール、飼料添加物などがあり、それぞれがアニマルヘルスと生産性の維持に不可欠です。最終用途の範囲は、農家やペットの飼い主だけでなく、動物病院、研究機関、製薬会社などにも広がっています。

市場の洞察によれば、診断薬と治療薬における技術の進歩、持続可能な畜産慣行への注目の高まり、新規治療のための研究開発への旺盛な投資など、成長に影響を与えるいくつかの重要な要因が明らかになっています。特に、畜産部門が拡大し、ペットヘルスケア市場が十分に整備されていない新興国市場にビジネスチャンスがあります。利害関係者にとっては、デジタル健康モニタリング・システムのような技術統合を優先し、急成長市場に進出することで成長を促進できる可能性があります。しかし、市場は厳しい規制環境、前衛技術の高コスト、抗生物質耐性の潜在的問題などの課題に直面しており、これらは進展の妨げになる可能性があります。

技術革新が必要とされる分野には、抗生物質に代わる治療法の開発、より広範な疾病をカバーするためのワクチン生産の強化、耐病性動物を作出するための遺伝子研究の改善などがあります。さらに、AIとIoTのモニタリングへの応用の増加は、正確な健康追跡とデータ主導の治療計画を可能にすることで、業界に革命をもたらす道筋を提供します。市場の性質はダイナミックで競争的であり、専門知識の統合とポートフォリオの拡充を目的とした頻繁な合併・買収が特徴です。現在の限界は、規制の枠組みを調和させる必要性と、可視性とアクセシビリティの障壁を克服するための教育への投資の必要性を強調しています。こうした課題に対処することで、市場は成長軌道を維持し、経済的・社会的配当が期待できるイノベーションを促進することができます。

市場力学：急速に進化するアニマルヘルス市場の主要市場インサイトを公開

アニマルヘルス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人獣共通感染症および食品媒介感染症の増加
  • 動物福祉の採用に対する政府の取り組みと支援
  • アニマルヘルスへの介入の増加に伴うペット飼育率の増加
• 市場抑制要因
  • 利用可能性と受容性の制限、獣医師の不足
• 市場機会
  • 革新的な新製品を発売するための研究開発活動の加速
  • ペット保険の利用可能性と採用率の上昇
• 市場の課題
  • 規制当局による抗生物質の使用制限

ポーターのファイブフォース：アニマルヘルス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：アニマルヘルス市場における外部からの影響の把握

外部マクロ環境要因は、アニマルヘルス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析アニマルヘルス市場における競合情勢の把握

アニマルヘルス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスアニマルヘルス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、アニマルヘルス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨アニマルヘルス市場における成功への道筋を描く

アニマルヘルス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人獣共通感染症および食中毒の発生率の増加
    • 動物福祉の導入に向けた政府の取り組みと支援
    • ペットの養子縁組率の増加とアニマルヘルスへの介入の増加
  • 抑制要因
    • 獣医師の不足と受け入れの制限
  • 機会
    • 革新的な新製品の発売に向けた研究開発活動の加速
    • ペット保険の利用可能性と採用の増加
  • 課題
    • 規制当局による抗生物質の使用に関する制限
• 市場セグメンテーション分析
  • 製品：健康を促進し病気を予防するための医薬品飼料添加物の使用が増加
  • エンドユーザー：獣医師によるアニマルヘルス製品の採用が拡大し、さまざまな環境でアニマルヘルスと福祉の維持に役立っています。
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 アニマルヘルス市場：製品別

• 生物学的製剤
  • ワクチン
    • 不活性化（殺された）
    • 修正/減衰ライブ
• 診断
  • 消耗品、試薬、キット
  • 機器とデバイス
• 機器と消耗品
  • 麻酔機器
  • クリティカルケア消耗品
  • 流体管理装置
  • 患者モニタリング装置
  • 救助・蘇生機器
  • 調査機器
  • 温度管理機器
• 医薬品飼料添加物
• 医薬品
  • 鎮痛剤
  • 抗感染薬
  • 抗炎症
  • 寄生虫駆除剤

第7章 アニマルヘルス市場動物の種類別

• ペット
  • 猫
  • 犬
  • 馬
• 農場の動物
  • 牛
  • 家禽
  • 羊とヤギ
  • 豚

第8章 アニマルヘルス市場：エンドユーザー別

• 農家と牧場主
• ペットの飼い主
• 獣医

第9章 南北アメリカのアニマルヘルス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のアニマルヘルス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのアニマルヘルス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • フィブロ・アニマル・ヘルス、ゾエティスの製品ポートフォリオを3億5,000万米ドルで買収し、世界展開と製造能力を強化
  • メルク社、エランコ社の買収により水産養殖事業を強化
  • MSDアニマルヘルス、魚の養殖の効率と福祉を変革するファルコンバイオマスを導入
• 戦略分析と提言

企業一覧

• BioChek BV
• bioMerieux SA
• Boehringer Ingelheim GmbH
• Cadila Healthcare Limited
• Ceva Animal Health LLC
• Covetrus, Inc.
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Heska Corporation
• HIPRA, S.A.
• IDEXX Laboratories, Inc.
• INDICAL Bioscience GmbH
• Merck & Co., Inc.
• Norbrook Holdings Limited
• Phibro Animal Health Corporation
• Randox Laboratories Ltd.
• Thermo Fisher Scientific, Inc
• Vetoquinol Group
• Virbac S.A
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL HEALTH MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL HEALTH MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ANIMAL HEALTH MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ANIMAL HEALTH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL HEALTH MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL HEALTH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL HEALTH MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INACTIVATED (KILLED), BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MODIFIED/ ATTENUATED LIVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CONSUMABLES, REAGENTS, & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL HEALTH MARKET SIZE, BY INSTRUMENTS & DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANESTHESIA EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CRITICAL CARE CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FLUID MANAGEMENT EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PATIENT MONITORING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RESCUE & RESUSCITATION EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANIMAL HEALTH MARKET SIZE, BY RESEARCH EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANIMAL HEALTH MARKET SIZE, BY TEMPERATURE MANAGEMENT EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANIMAL HEALTH MARKET SIZE, BY MEDICINAL FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL ANIMAL HEALTH MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL ANIMAL HEALTH MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL ANIMAL HEALTH MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL ANIMAL HEALTH MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL ANIMAL HEALTH MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL ANIMAL HEALTH MARKET SIZE, BY FARMERS & RANCHERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL ANIMAL HEALTH MARKET SIZE, BY PET OWNERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL ANIMAL HEALTH MARKET SIZE, BY VETERINARIANS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. CANADA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. CANADA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 83. CANADA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 84. CANADA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 85. CANADA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 86. CANADA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 87. CANADA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. CANADA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 89. CANADA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 90. CANADA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. MEXICO ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MEXICO ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 93. MEXICO ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 103. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 104. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES ANIMAL HEALTH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 112. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 114. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 116. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 123. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 125. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 126. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 127. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 128. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. CHINA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. CHINA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 135. CHINA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 136. CHINA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 137. CHINA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 138. CHINA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 139. CHINA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. CHINA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 141. CHINA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 142. CHINA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. INDIA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. INDIA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 145. INDIA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 146. INDIA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 147. INDIA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 148. INDIA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 149. INDIA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 150. INDIA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 151. INDIA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 152. INDIA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. INDONESIA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. INDONESIA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 155. INDONESIA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 156. INDONESIA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 157. INDONESIA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 158. INDONESIA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 159. INDONESIA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. INDONESIA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 161. INDONESIA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 162. INDONESIA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. JAPAN ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. JAPAN ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 165. JAPAN ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 166. JAPAN ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 167. JAPAN ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 168. JAPAN ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 169. JAPAN ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 170. JAPAN ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 171. JAPAN ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 172. JAPAN ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 175. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 176. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 177. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 178. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 179. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 181. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 182. MALAYSIA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 185. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 186. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 187. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 188. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 189. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 190. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 191. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 192. PHILIPPINES ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 195. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 196. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 197. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 198. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 199. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 200. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 201. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 202. SINGAPORE ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH KOREA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. TAIWAN ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 214. TAIWAN ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 215. TAIWAN ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 216. TAIWAN ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 217. TAIWAN ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 218. TAIWAN ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 219. TAIWAN ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 220. TAIWAN ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 221. TAIWAN ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 222. TAIWAN ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. THAILAND ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 224. THAILAND ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 225. THAILAND ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 226. THAILAND ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 227. THAILAND ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 228. THAILAND ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 229. THAILAND ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 230. THAILAND ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 231. THAILAND ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 232. THAILAND ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. VIETNAM ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 234. VIETNAM ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 235. VIETNAM ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 236. VIETNAM ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 237. VIETNAM ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 238. VIETNAM ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 239. VIETNAM ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 240. VIETNAM ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 241. VIETNAM ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 242. VIETNAM ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 254. DENMARK ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 255. DENMARK ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 256. DENMARK ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 257. DENMARK ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 258. DENMARK ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 259. DENMARK ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 260. DENMARK ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 261. DENMARK ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 262. DENMARK ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 263. DENMARK ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 264. EGYPT ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 265. EGYPT ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 266. EGYPT ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 267. EGYPT ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 268. EGYPT ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 269. EGYPT ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 270. EGYPT ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 271. EGYPT ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 272. EGYPT ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 273. EGYPT ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. FINLAND ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. FINLAND ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 276. FINLAND ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 277. FINLAND ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 278. FINLAND ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 279. FINLAND ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 280. FINLAND ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 281. FINLAND ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 282. FINLAND ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 283. FINLAND ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 284. FRANCE ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. FRANCE ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 286. FRANCE ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 287. FRANCE ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 288. FRANCE ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 289. FRANCE ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 290. FRANCE ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 291. FRANCE ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 292. FRANCE ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 293. FRANCE ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 294. GERMANY ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 295. GERMANY ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 296. GERMANY ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 297. GERMANY ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 298. GERMANY ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 299. GERMANY ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 300. GERMANY ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 301. GERMANY ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 302. GERMANY ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 303. GERMANY ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 304. ISRAEL ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 305. ISRAEL ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 306. ISRAEL ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 307. ISRAEL ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 308. ISRAEL ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 309. ISRAEL ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 310. ISRAEL ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 311. ISRAEL ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 312. ISRAEL ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 313. ISRAEL ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 314. ITALY ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 315. ITALY ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 316. ITALY ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 317. ITALY ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 318. ITALY ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 319. ITALY ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 320. ITALY ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 321. ITALY ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 322. ITALY ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 323. ITALY ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 324. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 325. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 326. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 327. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 328. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 329. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 330. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 331. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 332. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 333. NETHERLANDS ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 334. NIGERIA ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 335. NIGERIA ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 336. NIGERIA ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 337. NIGERIA ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 338. NIGERIA ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 339. NIGERIA ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 340. NIGERIA ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 341. NIGERIA ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 342. NIGERIA ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 343. NIGERIA ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 344. NORWAY ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 345. NORWAY ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 346. NORWAY ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 347. NORWAY ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 348. NORWAY ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 349. NORWAY ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 350. NORWAY ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 351. NORWAY ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 352. NORWAY ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 353. NORWAY ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 354. POLAND ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 355. POLAND ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 356. POLAND ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 357. POLAND ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 358. POLAND ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 359. POLAND ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 360. POLAND ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 361. POLAND ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 362. POLAND ANIMAL HEALTH MARKET SIZE, BY FARM ANIMAL, 2018-2030 (USD MILLION)
• TABLE 363. POLAND ANIMAL HEALTH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 364. QATAR ANIMAL HEALTH MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 365. QATAR ANIMAL HEALTH MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
• TABLE 366. QATAR ANIMAL HEALTH MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
• TABLE 367. QATAR ANIMAL HEALTH MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 368. QATAR ANIMAL HEALTH MARKET SIZE, BY EQUIPMENT & DISPOSABLES, 2018-2030 (USD MILLION)
• TABLE 369. QATAR ANIMAL HEALTH MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
• TABLE 370. QATAR ANIMAL HEALTH MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 371. QATAR ANIMAL HEALTH MARKET SIZE, BY COMPANION ANIMA

The Animal Health Market was valued at USD 83.85 billion in 2023, expected to reach USD 90.62 billion in 2024, and is projected to grow at a CAGR of 8.38%, to USD 147.38 billion by 2030.

The scope of the animal health market encompasses industries and sectors involved in the prevention, diagnosis, and treatment of diseases affecting animals, ranging from livestock and poultry to companion animals. This market plays a crucial role in ensuring food safety, public health, and animal welfare. The necessity of this market arises from the growing prevalence of zoonotic diseases, increasing livestock production to meet rising protein demand, and the human-animal bond's enhancement fueling the pet industry. Applications include pharmaceuticals, vaccines, diagnostic tools, and feed additives, each critical in maintaining animal health and productivity. The end-use scope extends beyond farmers and pet owners to include veterinary hospitals, research institutions, and pharmaceutical companies.

Market insights reveal several key factors influencing growth: advancing technology in diagnostics and therapeutics, a heightened focus on sustainable livestock practices, and robust investment in R&D for novel treatments. Opportunities arise particularly in developing regions with expanding livestock sectors and underserved pet healthcare markets. For stakeholders, prioritizing technological integration, like digital health monitoring systems, and expanding to burgeoning markets could leverage growth. However, the market faces challenges such as strict regulatory environments, the high cost of avant-garde technologies, and potential antibiotic resistance issues, which may impede progress.

Areas ripe for innovation include developing alternative treatments to antibiotics, enhancing vaccine production for broader disease coverage, and improving genetic research to engineer disease-resistant animals. Additionally, the increased application of AI and IoT in animal health monitoring offers pathways to revolutionize the industry by enabling precise health tracking and data-driven treatment plans. The nature of the market is dynamic and competitive, characterized by frequent mergers and acquisitions aiming to consolidate expertise and broaden portfolio offerings. Current limitations emphasize the need for harmonized regulatory frameworks and investment in education to overcome visibility and accessibility barriers. By addressing these challenges, the market can continue its growth trajectory, while fostering innovations that promise both economic and social dividends.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Health Market

The Animal Health Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of zoonotic and food-borne diseases
  • Government initiative and support for the adoption of animal welfare
  • Growing rate of pet adoption with increased intervention toward animal health
• Market Restraints
  • Limited availability and acceptance and dearth of veterinarians
• Market Opportunities
  • Accelerating research and development activities for launching new and innovative products
  • Rising availability and adoption of pet insurance
• Market Challenges
  • Restrictions imposed by regulatory authorities on the use of antibiotics

Porter's Five Forces: A Strategic Tool for Navigating the Animal Health Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Health Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Health Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Health Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Health Market

A detailed market share analysis in the Animal Health Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Health Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Health Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Health Market

A strategic analysis of the Animal Health Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Health Market, highlighting leading vendors and their innovative profiles. These include BioChek BV, bioMerieux SA, Boehringer Ingelheim GmbH, Cadila Healthcare Limited, Ceva Animal Health LLC, Covetrus, Inc., Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Heska Corporation, HIPRA, S.A., IDEXX Laboratories, Inc., INDICAL Bioscience GmbH, Merck & Co., Inc., Norbrook Holdings Limited, Phibro Animal Health Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific, Inc, Vetoquinol Group, Virbac S.A, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Biologics, Diagnostics, Equipment & Disposables, Medicinal Feed Additives, and Pharmaceuticals. The Biologics is further studied across Vaccine. The Vaccine is further studied across Inactivated (Killed) and Modified/ Attenuated Live. The Diagnostics is further studied across Consumables, Reagents, & Kits and Instruments & Devices. The Equipment & Disposables is further studied across Anesthesia Equipment, Critical Care Consumables, Fluid Management Equipment, Patient Monitoring Equipment, Rescue & Resuscitation Equipment, Research Equipment, and Temperature Management Equipment. The Pharmaceuticals is further studied across Analgesics, Anti-infectives, Anti-inflammatory, and Parasiticides.
• Based on Animal Type, market is studied across Companion Animal and Farm Animal. The Companion Animal is further studied across Cats, Dogs, and Horses. The Farm Animal is further studied across Cattle, Poultry, Sheep & Goats, and Swine.
• Based on End User, market is studied across Farmers & Ranchers, Pet Owners, and Veterinarians.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of zoonotic and food-borne diseases
    • 5.1.1.2. Government initiative and support for the adoption of animal welfare
    • 5.1.1.3. Growing rate of pet adoption with increased intervention toward animal health
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and acceptance and dearth of veterinarians
  • 5.1.3. Opportunities
    • 5.1.3.1. Accelerating research and development activities for launching new and innovative products
    • 5.1.3.2. Rising availability and adoption of pet insurance
  • 5.1.4. Challenges
    • 5.1.4.1. Restrictions imposed by regulatory authorities on the use of antibiotics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of medicinal feed additives to promote health and prevent diseases
  • 5.2.2. End User: Growing adoption of animal health products by veterinarians for the maintenance of animal health and welfare across different settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Health Market, by Product

• 6.1. Introduction
• 6.2. Biologics
  • 6.2.1. Vaccine
    • 6.2.1.1. Inactivated (Killed)
    • 6.2.1.2. Modified/ Attenuated Live
• 6.3. Diagnostics
  • 6.3.1. Consumables, Reagents, & Kits
  • 6.3.2. Instruments & Devices
• 6.4. Equipment & Disposables
  • 6.4.1. Anesthesia Equipment
  • 6.4.2. Critical Care Consumables
  • 6.4.3. Fluid Management Equipment
  • 6.4.4. Patient Monitoring Equipment
  • 6.4.5. Rescue & Resuscitation Equipment
  • 6.4.6. Research Equipment
  • 6.4.7. Temperature Management Equipment
• 6.5. Medicinal Feed Additives
• 6.6. Pharmaceuticals
  • 6.6.1. Analgesics
  • 6.6.2. Anti-infectives
  • 6.6.3. Anti-inflammatory
  • 6.6.4. Parasiticides

7. Animal Health Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animal
  • 7.2.1. Cats
  • 7.2.2. Dogs
  • 7.2.3. Horses
• 7.3. Farm Animal
  • 7.3.1. Cattle
  • 7.3.2. Poultry
  • 7.3.3. Sheep & Goats
  • 7.3.4. Swine

8. Animal Health Market, by End User

• 8.1. Introduction
• 8.2. Farmers & Ranchers
• 8.3. Pet Owners
• 8.4. Veterinarians

9. Americas Animal Health Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Animal Health Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Animal Health Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Phibro Animal Health's USD 350 Million Acquisition of Zoetis' Product Portfolio to Boost Global Reach and Manufacturing Capacity
  • 12.3.2. Merck & Co., Inc. Strengthens Aquaculture Presence with Elanco Animal Health Acquisition
  • 12.3.3. MSD Animal Health Introduces Falcon Biomass to Revolutionize Fish Farming Efficiency and Welfare
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BioChek BV
• 2. bioMerieux SA
• 3. Boehringer Ingelheim GmbH
• 4. Cadila Healthcare Limited
• 5. Ceva Animal Health LLC
• 6. Covetrus, Inc.
• 7. Dechra Pharmaceuticals PLC
• 8. Elanco Animal Health Incorporated
• 9. Heska Corporation
• 10. HIPRA, S.A.
• 11. IDEXX Laboratories, Inc.
• 12. INDICAL Bioscience GmbH
• 13. Merck & Co., Inc.
• 14. Norbrook Holdings Limited
• 15. Phibro Animal Health Corporation
• 16. Randox Laboratories Ltd.
• 17. Thermo Fisher Scientific, Inc
• 18. Vetoquinol Group
• 19. Virbac S.A
• 20. Zoetis Inc.